Laparoskopisk intraperitoneal kemoterapi under tryk (PIPAC) til behandling af peritoneale metastaser

Translated title of the contribution: Pressurised intraperitoneal aerosol chemotherapy (PIPAC) for the treatment of peritoneal metastases

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Pressurised intraperitoneal aerosol chemotherapy (PIPAC) was introduced in Denmark in 2015. More than 100 Danish patients with peritoneal metastases (PM) have received PIPAC-directed treatment within the PIPAC-OPC1 and PIPAC-OPC2 trials. PIPAC-directed treatment is feasible and safe, and there are no occupational risks for the involved healthcare professionals. An objective tumour response is seen in two out of three patients, and the survival data warrant further evaluation in large-scale randomised trials in patients with PM from different primary tumours.
Translated title of the contributionPressurised intraperitoneal aerosol chemotherapy (PIPAC) for the treatment of peritoneal metastases
Original languageDanish
Article numberV04190224
JournalUgeskrift for Laeger
Volume181
Issue number20A
ISSN0041-5782
Publication statusPublished - 14. Oct 2019

Fingerprint Dive into the research topics of 'Pressurised intraperitoneal aerosol chemotherapy (PIPAC) for the treatment of peritoneal metastases'. Together they form a unique fingerprint.

Cite this